ASCO highlights podcast: head and neck cancers

Autor Merlano, Marco
Vydáno v ESMO Open (2016)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck

Autor Merlano, Marco, Occelli, Marcella
Vydáno 2007

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?

Autor Merlano, Marco C, Garrone, Ornella
Vydáno v ESMO Open (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer

Autor Denaro, Nerina, Merlano, Marco Carlo
Vydáno v Clin Exp Otorhinolaryngol (2018)

Immune-related response criteria: light and shadows

Autor Merlano, Marco, Occelli, Marcella, Garrone, Ornella
Vydáno v ESMO Open (2016)

Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations

Autor Denaro, Nerina, Merlano, Marco C., Russi, Elvio G.
Vydáno 2013

Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience

Autor Denaro, Nerina, Merlano, Marco Carlo, Russi, Elvio Grazioso
Vydáno v Clin Exp Otorhinolaryngol (2016)

Long noncoding RNAs as regulators of cancer immunity

Autor Denaro, Nerina, Merlano, Marco Carlo, Lo Nigro, Cristiana
Vydáno v Mol Oncol (2018)

Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis

Autor Denaro, Nerina, Merlano, Marco Carlo, Lo Nigro, Cristiana
Vydáno v Cancer Manag Res (2021)

Head and neck cancer: improving outcomes with a multidisciplinary approach

Autor Lo Nigro, Cristiana, Denaro, Nerina, Merlotti, Anna, Merlano, Marco
Vydáno v Cancer Manag Res (2017)

How I treat squamous ENT cancer

Autor Merlano, Marco Carlo, Denaro, Nerina, Galizia, Danilo, Garrone, Ornella
Vydáno v ESMO Open (2019)

Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)

Autor Denaro, Nerina, Merlotti, Anna Maria, Merlano, Marco Carlo, Russi, Elvio
Vydáno v Oral Oncol (2020)

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

Autor Denaro, Nerina, Nigro, Cristiana Lo, Russi, Elvio G, Merlano, Marco C
Vydáno 2013

Heterogeneity of colon cancer: from bench to bedside

Autor Merlano, Marco C, Granetto, Cristina, Fea, Elena, Ricci, Vincenzo, Garrone, Ornella
Vydáno v ESMO Open (2017)

NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives

Autor Lo Nigro, Cristiana, Macagno, Marco, Sangiolo, Dario, Bertolaccini, Luca, Aglietta, Massimo, Merlano, Marco Carlo
Vydáno v Ann Transl Med (2019)

Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review

Autor Denaro, Nerina, Garrone, Ornella, Occelli, Marcella, Fea, Elena, Granetto, Cristina, Merlano, Marco Carlo, Numico, Gianmauro
Vydáno v Eur J Case Rep Intern Med (2021)

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy

Autor Lo Nigro, Cristiana, Ricci, Vincenzo, Vivenza, Daniela, Granetto, Cristina, Fabozzi, Teresa, Miraglio, Emanuela, Merlano, Marco C
Vydáno v World J Gastroenterol (2016)

DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer

Autor Lo Nigro, Cristiana, Vivenza, Daniela, Denaro, Nerina, Lattanzio, Laura, Fortunato, Mirella, Crook, Tim, Merlano, Marco Carlo
Vydáno v Ann Transl Med (2018)

Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

Autor Pinto, Carmine, Barone, Carlo Antonio, Girolomoni, Giampiero, Russi, Elvio Grazioso, Merlano, Marco Carlo, Ferrari, Daris, Maiello, Evaristo
Vydáno 2011

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies

Autor Guyot, Mélanie, Hilmi, Caroline, Ambrosetti, Damien, Merlano, Marco, Nigro, Cristiana Lo, Durivault, Jérôme, Grépin, Renaud, Pagès, Gilles
Vydáno v Oncotarget (2016)